Non-invasive Exhaled Breath and Skin Analysis to Diagnose Lung Cancer: Study of Age Effect on Diagnostic Accuracy.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
22 Nov 2022
Historique:
received: 22 09 2022
accepted: 01 11 2022
entrez: 28 11 2022
pubmed: 29 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

Development of simple, fast, and non-invasive tests for lung cancer diagnostics is essential for clinical practice. In this paper, exhaled breath and skin were studied as potential objects to diagnose lung cancer. The influence of age on the performance of diagnostic models was studied. Gas chromatography in combination with mass spectrometry (MS) was used to analyze the exhaled breath of 110 lung cancer patients and 212 healthy individuals of various ages. Peak area ratios of volatile organic compounds (VOCs) were used for data analysis instead of VOC peak areas. Various machine learning algorithms were applied to create diagnostic models, and their performance was compared. The best results on the test data set were achieved using artificial neural networks (ANNs): classification of patients with lung cancer and young healthy volunteers: 88 ± 4% sensitivity and 83 ± 3% specificity; classification of patients with lung cancer and old healthy individuals: 81 ± 3% sensitivity and 85 ± 1% specificity. The difference between performance of models based on young and old healthy groups was minor. The results obtained have shown that metabolic dysregulation driven by the disease biology is too high, which significantly overlaps the age effect. The influence of tumor localization and histological type on exhaled breath samples of lung cancer patients was studied. Statistically significant differences between some parameters in these samples were observed. A possibility of assessing the disease status by skin analysis in the Zakharyin-Ged zones using an electronic nose based on the quartz crystal microbalance sensor system was evaluated. Diagnostic models created using ANNs allow us to classify the skin composition of patients with lung cancer and healthy subjects of different ages with a sensitivity of 69 ± 2% and a specificity of 68 ± 8% for the young healthy group and a sensitivity of 74 ± 7% and a specificity of 66 ± 6% for the old healthy group. Primary results of skin analysis in the Zakharyin-Ged zones for the lung cancer diagnosis have shown its utility, but further investigation is required to confirm the results obtained.

Identifiants

pubmed: 36440120
doi: 10.1021/acsomega.2c06132
pmc: PMC9685768
doi:

Types de publication

Journal Article

Langues

eng

Pagination

42613-42628

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Adv Sci (Weinh). 2021 Aug;8(15):e2100235
pubmed: 34075714
Heliyon. 2020 Jun 17;6(6):e04224
pubmed: 32577579
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Breath Res. 2019 Jun 04;13(3):039002
pubmed: 31085815
Lung Cancer. 2010 May;68(2):170-6
pubmed: 19959252
Nanomedicine. 2013 Jan;9(1):15-21
pubmed: 22967910
J Thorac Oncol. 2012 Jan;7(1):137-42
pubmed: 22071780
J Breath Res. 2017 Apr 25;11(2):026004
pubmed: 28440225
Lung Cancer. 2010 Feb;67(2):227-31
pubmed: 19409642
ERJ Open Res. 2020 Mar 16;6(1):
pubmed: 32201682
Anal Chim Acta. 2019 Jan 3;1045:10-22
pubmed: 30454564
J Breath Res. 2016 Feb 09;10(1):016007
pubmed: 26857451
Anal Methods. 2021 Oct 21;13(40):4793-4804
pubmed: 34581316
Lung Cancer. 2021 Apr;154:206-213
pubmed: 33563485
JAMA Netw Open. 2021 Mar 1;4(3):e213486
pubmed: 33783517
J Acupunct Meridian Stud. 2018 Feb;11(1):31-38
pubmed: 29482799
J Breath Res. 2015 Jan 29;9(2):027101
pubmed: 25634546
J Breath Res. 2019 Apr 01;13(3):034001
pubmed: 30754033
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:146-153
pubmed: 30745111
PLoS One. 2014 Dec 09;9(12):e114555
pubmed: 25490772
Analyst. 2014 Sep 7;139(17):4279-86
pubmed: 24992564
J Breath Res. 2016 Oct 12;10(4):046007
pubmed: 27732569
J Breath Res. 2017 Aug 21;11(3):036009
pubmed: 28585921
Biochim Biophys Acta Rev Cancer. 2022 Jan;1877(1):188644
pubmed: 34737023
Biosensors (Basel). 2021 Sep 14;11(9):
pubmed: 34562928
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 12;911:84-92
pubmed: 23217311
J Breath Res. 2015 May 06;9(2):027106
pubmed: 25944812
Future Oncol. 2018 Jul;14(16):1647-1662
pubmed: 29939068

Auteurs

Elina Gashimova (E)

Department of Analytical Chemistry, Kuban State University, Krasnodar350040, Russia.

Azamat Temerdashev (A)

Department of Analytical Chemistry, Kuban State University, Krasnodar350040, Russia.

Vladimir Porkhanov (V)

Research Institute-Regional Clinical Hospital No 1 n.a. Prof. S.V. Ochapovsky, Krasnodar350086, Russia.

Igor Polyakov (I)

Research Institute-Regional Clinical Hospital No 1 n.a. Prof. S.V. Ochapovsky, Krasnodar350086, Russia.

Dmitry Perunov (D)

Research Institute-Regional Clinical Hospital No 1 n.a. Prof. S.V. Ochapovsky, Krasnodar350086, Russia.

Ekaterina Dmitrieva (E)

Department of Analytical Chemistry, Kuban State University, Krasnodar350040, Russia.

Classifications MeSH